The lancet. Diabetes & endocrinology
-
Lancet Diabetes Endocrinol · Jul 2017
Randomized Controlled Trial Multicenter Study10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.
Long-term safety and efficacy of osteoporosis treatment are important because of the chronic nature of the disease. We aimed to assess the long-term safety and efficacy of denosumab, which is widely used for the treatment of postmenopausal women with osteoporosis. ⋯ Amgen.